Clinical Trial for the Evaluation of Melatonin in the Treatment of Pressure Ulcers
Status:
NOT_YET_RECRUITING
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
Melatonin has been shown to prevent cellular damage produced by oxidative stress or in situations of ischaemia, inhibiting the synthesis of oxidants and pro inflammatory factors such as pro-inflammatory cytokines, substances which are present in pressure ulcers and can affect the healing process, slowing it down. Melatonin gel has also been shown to prevent ulcers in the oral mucosa due to radiotherapy. Therefore, the hypothesis for this study is that the melatonin cream provides greater ulcer area reduction than standard pressure ulcer treatment.
Phase:
NA
Details
Lead Sponsor:
Fundacion Rioja Salud
Collaborators:
Instituto de Salud Carlos III Pharmamel S.L. Universidad de Granada